Evidence map›Paper›PMID 29272273›Full record

ArticlePloS one2017

Higher-than-expected prevalence of non-tuberculous mycobacteria in HIV setting in Botswana: Implications for diagnostic algorithms using Xpert MTB/RIF assay.

Tefera Agizew, Joyce Basotli, Heather Alexander, Rosanna Boyd, Gaoraelwe Letsibogo, Andrew Auld, Sambayawo Nyirenda, Zegabriel Tedla, Anikie Mathoma, Unami Mathebula and 3 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 4 pooled it
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 4 syntheses or guidelines pooled it, 32 citations in OpenAlex.

  1. Prevalence ofFrontiers in microbiology · 2024
    Pooled it
  2. A systematic review of the number needed to screen for active TB among people living with HIV.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2021
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Challenges in the Diagnosis and Treatment of Mycobacterium abscessus Infections.Revista da Sociedade Brasileira de Medicina Tropical · 2026
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Non-Mycobacteria Tuberculosis in Africa: A Literature Review.Ethiopian journal of health sciences · 2023
    Review
  13. Article
  14. Article
  15. Non-Tuberculous Mycobacterial Pulmonary Disease identified during community-based screening forMalawi medical journal : the journal of Medical Association of Malawi · 2021
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 2 countries.

Tefera AgizewCenters for Disease Control and Prevention, Gaborone, Botswana.ORCID 0000-0003-1848-7307
Joyce BasotliCenters for Disease Control and Prevention, Gaborone, Botswana.
Heather AlexanderCenters for Disease Control and Prevention, Division of Global HIV and TB, Atlanta, Georgia, United States of America.
Rosanna BoydCenters for Disease Control and Prevention, Gaborone, Botswana.
Gaoraelwe LetsibogoNational Tuberculosis Reference Laboratory, Ministry of Health, Gaborone, Botswana.
Andrew AuldCenters for Disease Control and Prevention, Division of Global HIV and TB, Atlanta, Georgia, United States of America.
Sambayawo NyirendaCenters for Disease Control and Prevention, Gaborone, Botswana.
Zegabriel TedlaCenters for Disease Control and Prevention, Gaborone, Botswana.
Anikie MathomaCenters for Disease Control and Prevention, Gaborone, Botswana.
Unami MathebulaCenters for Disease Control and Prevention, Gaborone, Botswana.
Sherri PalsCenters for Disease Control and Prevention, Division of Global HIV and TB, Atlanta, Georgia, United States of America.
Anand DateCenters for Disease Control and Prevention, Division of Global HIV and TB, Atlanta, Georgia, United States of America.
Alyssa FinlayCenters for Disease Control and Prevention, Gaborone, Botswana.
Centers for Disease Control and Prevention · USMinistry of Health · BW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNon-tuberculous mycobacteria (NTM) can cause pulmonary infection and disease especially among people living with HIV (PLHIV). PLHIV with NTM disease may clinically present with one of the four symptoms consistent with tuberculosis (TB). We describe the prevalence of NTM and Mycobacterium tuberculosis complex (MTBC) isolated among PLHIV who presented for HIV care and treatment.

methodsAll PLHIV patients presenting for HIV care and treatment services at 22 clinical sites in Botswana were offered screening for TB and were recruited. Patients who had ≥1 TB symptom were asked to submit sputa for Xpert MTB/RIF and culture. Culture growth was identified as NTM and MTBC using the SD-Bioline TB Ag MPT64 Kit and Ziehl Neelsen microscopy. NTM and MTBC isolates underwent species identification by the Hain GenoType CM and AS line probe assays.

resultsAmong 16, 259 PLHIV enrolled 3068 screened positive for at least one TB symptom. Of these, 1940 submitted ≥1 sputum specimen, 427 (22%) patients had ≥1 positive-culture result identified phenotypically for mycobacterial growth. Of these 247 and 180 patients were identified as having isolates were NTM and MTBC, respectively. Of the 247 patients identified with isolates containing NTM; 19 were later excluded as not having NTM based on additional genotypic testing. Among the remaining 408 patients 228 (56%, 95% confidence interval, 46-66%) with NTM. M. intracellulare was the most common isolated (47.8%). Other NTMs commonly associated with pulmonary disease included M. malmoense (3.9%), M. avium (2.2%), M. abscessus (0.9%) and M. kansasii (0.4%). After excluding NTM isolates that were non-speciated and M. gordonae 154 (67.5%) of the NTM isolates were potential pathogens.

conclusionsIn the setting of HIV care and treatment, over-half (56%) of a positive sputum culture among PLHIV with TB symptoms was NTM. Though we were not able to distinguish in our study NTM disease and colonization, the study suggests culture and species identification for PLHIV presenting with TB symptoms remains important to facilitate NTM diagnosis and hasten time to appropriate treatment.

Indexed as

AlgorithmsAdultBotswanaFemaleHIV InfectionsHumansMaleMiddle AgedMycobacterium Infections, NontuberculousNontuberculous MycobacteriaPrevalence

Identifiers

PMID29272273
PMCPMC5741233
OpenAlexW2781237459

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.